Clonazepam Orally Disintegrating Tablets recalled over labeling errors
- Recall date
- July 17, 2024
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Endo USA, Inc recalls Par Pharmaceutical — Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets
- Brand / firm
- Endo USA, Inc, Par Pharmaceutical
Why it was recalled
Mislabeled with the incorrect strength on the carton — Mislabeling
What was recalled
Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Endo USA, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Endo USA, Inc, Par Pharmaceutical